Net Cash Provided by (Used in) Operating Activities |
-126K |
USD |
+11% |
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
103K |
USD |
-3.3% |
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q4 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
2B |
shares |
0% |
Q1 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
925M |
shares |
+12.1% |
Q1 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-23.1K |
USD |
+31.2% |
Q4 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
36.8K |
USD |
+69.8% |
Q1 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
156 |
USD |
-28.8% |
Q4 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
2.38M |
USD |
+9.37% |
Q3 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-657K |
USD |
-11.3% |
Q1 2025 |
Q2 2025 |
Property, Plant and Equipment, Gross |
23.9K |
USD |
0% |
Q3 2023 |
FY 2023 |
Deferred Tax Assets, Operating Loss Carryforwards |
2.05M |
USD |
+10.8% |
Q3 2024 |
FY 2024 |
Additional Paid in Capital |
10.1M |
USD |
+2.85% |
Q1 2025 |
Q2 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2024 |
FY 2024 |
Interest Expense |
459K |
USD |
+52.3% |
Q2 2024 |
Q3 2024 |